NCT03242642

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,056 (estimated)
• Sponsor: Medtronic Cardiovascular · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.

Conditions

• Mitral Valve Regurgitation

Interventions

Type	Name	Description
DEVICE	Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)	mitral valve replacement
DEVICE	Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)	Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR) mitral valve replacement

Timeline

• Start date: 2017-10-23
• Primary completion: 2027-05-30
• Completion: 2036-09-30
• First posted: 2017-08-08
• Last updated: 2026-03-31

Locations

85 sites across 3 countries: United States, Canada, Denmark

Regulatory

• FDA-regulated device study